Skip to main content
Clinical Trials/NCT02811705
NCT02811705CompletedNot Applicable

Life Quality Study for PFAPA Patient

Versailles Hospital2 sites in 1 country60 target enrollmentStarted: July 2015Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
60
Locations
2
Primary Endpoint
Compare quality of life from patients with PFAPA and FMF, reported by parents and by patients themselves

Study Overview

Brief Summary

This cohort study aims to assess the quality of life (or welfare) related to the health of children and adolescents with an non genetics auto-inflammatory disease PFAPA or Marshall syndrome to compare it to children or adolescents with recurrent fever genetics of Familial Mediterranean fever (FMF) in order to improve their overall care.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
2 Years to 18 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • PFAPA syndrome patients or FMF patients

Exclusion Criteria

  • Participation refusal

Outcomes

Primary Outcomes

Compare quality of life from patients with PFAPA and FMF, reported by parents and by patients themselves

Time Frame: 1 day

Secondary Outcomes

  • Evaluate the fatigue status of patients through questionnaire PedsQL TM 3.0 multidimensional scale tiredness(1 day)

Investigators

Sponsor
Versailles Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Véronique Hentgen

Dr

Versailles Hospital

Study Sites (2)

Loading locations...

Similar Trials